bretylium has been researched along with amiodarone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chamberlain, D; von Planta, M | 1 |
| Aussel, C; Pelassy, C | 1 |
| Satoh, H | 1 |
| Horrigan, TP; Mostow, ND; Noon, DL; Rosalion, A; Snow, NJ | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Roy, D | 1 |
| Anderson, JL | 1 |
| Morganroth, J; Nestico, PF | 1 |
| Holt, DW; Leatham, EW; McKenna, WJ | 1 |
| Bharucha, D; Kowey, PR; Marinchak, RA; Rials, SJ | 1 |
| Olshansky, B | 1 |
| Kudenchuk, PJ | 1 |
| Ehlers, J; Martin, G; O'Mara, K; Stoner, J; Tomlanovich, M | 1 |
| DeBisschop, M; Lower, DL; Martin, LG; Yamreudeewong, W | 1 |
| Dorian, P; Sarkozy, A | 1 |
| Al Raisi, M; Lang, E | 1 |
| Brignardello-Petersen, R; Cheskes, S; Guyatt, G; Iansavichene, A; McLeod, SL; Worster, A; You, J | 1 |
11 review(s) available for bretylium and amiodarone
| Article | Year |
|---|---|
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Rationale of combination antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Digitalis Glycosides; Drug Therapy, Combination; Humans; Mexiletine; Myocardial Infarction; Quinidine; Tachycardia; Verapamil | 1985 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Class III antiarrhythmics in overdose. Presenting features and management principles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biological Availability; Bretylium Compounds; Drug Overdose; Humans; Sotalol | 1993 |
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamines; Sotalol; Sulfonamides | 1997 |
Advanced cardiac life support antiarrhythmic drugs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Arrest; Humans; Lidocaine; Life Support Care; Magnesium; Male; Procainamide; Treatment Outcome | 2002 |
Potentially significant drug interactions of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides | 2003 |
Strategies for reversing shock-resistant ventricular fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Electric Countershock; Heart Arrest; Hemodynamics; Humans; Lidocaine; Magnesium; Procainamide; Vasoconstrictor Agents; Vasopressins; Ventricular Fibrillation | 2003 |
Ventricular tachyarrhythmias (out of hospital cardiac arrests).
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Electric Countershock; Humans; Lidocaine; Tachycardia, Ventricular | 2006 |
Comparative effectiveness of antiarrhythmics for out-of-hospital cardiac arrest: A systematic review and network meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Humans; Lidocaine; Network Meta-Analysis; Out-of-Hospital Cardiac Arrest; Randomized Controlled Trials as Topic | 2017 |
8 other study(ies) available for bretylium and amiodarone
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Atropine; Bretylium Compounds; Calcium; Cardiopulmonary Resuscitation; Combined Modality Therapy; Electric Countershock; Humans; Lidocaine; Magnesium; Ventricular Fibrillation | 1992 |
Effects of antiarrhythmic drugs on phospholipid metabolism in Jurkat T cells. The potassium channel blocker, clofilium, specifically increases phosphatidylserine synthesis.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Carboxy-Lyases; Choline; Decarboxylation; Dose-Response Relationship, Drug; Ethanolamine; Ethanolamines; Humans; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phospholipids; Propranolol; Quaternary Ammonium Compounds; T-Lymphocytes | 1992 |
Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.
Topics: Action Potentials; Amiodarone; Animals; Bretylium Compounds; Membrane Potentials; Rabbits; Sinoatrial Node; Sotalol | 1991 |
Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Dogs; Drug Evaluation, Preclinical; Heart Rate; Myocardial Reperfusion; Tachycardia; Ventricular Fibrillation | 1991 |
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinical Trials as Topic; Education, Medical, Continuing; Humans; Lidocaine; Postoperative Care; Procainamide; Tachycardia, Ventricular; Ventricular Fibrillation | 1998 |
Amiodarone and bretylium in the treatment of hypothermic ventricular fibrillation in a canine model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Disease Models, Animal; Dogs; Hypothermia, Induced; Random Allocation; Ventricular Fibrillation | 2003 |